Holen Sie sich die Stockscreener-App
0.3381
1.26%
-0.0043
Handel nachbörslich:
.34
0.0019
+0.56%
Schlusskurs vom Vortag:
$0.3424
Offen:
$0.3499
24-Stunden-Volumen:
318.05K
Relative Volume:
0.33
Marktkapitalisierung:
$24.52M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.35M
KGV:
-0.7424
EPS:
-0.4554
Netto-Cashflow:
$-5.51M
1W Leistung:
+5.82%
1M Leistung:
-24.87%
6M Leistung:
-75.32%
1J Leistung:
-24.55%
1-Tages-Spanne:
$0.3381
$0.3558
1-Wochen-Bereich:
$0.3129
$0.36
52-Wochen-Spanne:
$0.1135
$3.9099
Klotho Neurosciences Inc Stock (KLTO) Company Profile
Firmenname
Klotho Neurosciences Inc
Sektor
Branche
Telefon
(833) 931-6330
Adresse
13576 WALNUT STREET, SUITE A, OMAHA
Vergleichen Sie KLTO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KLTO
Klotho Neurosciences Inc
|
0.3381 | 24.84M | 0 | -11.35M | -5.51M | -0.4554 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Klotho Neurosciences Inc Aktie (KLTO) Neueste Nachrichten
Can Klotho Neurosciences Inc. stock beat analyst upgrades2025 Growth vs Value & Reliable Breakout Stock Forecasts - ulpravda.ru
Klotho Neurosciences to Present at the Biotech Showcase 2026 - Sahm
Why Klotho Neurosciences Inc. stock could rally in 2025July 2025 Analyst Calls & Real-Time Volume Analysis - ulpravda.ru
Is Klotho Neurosciences Inc. stock a top momentum playJuly 2025 Opening Moves & Stock Portfolio Risk Management - ulpravda.ru
Is Klotho Neurosciences Inc. stock recession proofJuly 2025 Sector Moves & Low Risk High Reward Ideas - ulpravda.ru
Can Klotho Neurosciences Inc. stock beat market expectations this quarterWeekly Trade Report & Verified Technical Signals - ulpravda.ru
Will Klotho Neurosciences Inc. Equity Warrant stock recover faster than peersMarket Activity Summary & Community Verified Swing Trade Signals - ulpravda.ru
Will Klotho Neurosciences Inc. stock benefit from sector rotationMarket Performance Recap & High Conviction Trade Alerts - ulpravda.ru
How Klotho Neurosciences Inc. Equity Warrant stock compares to growth peersJuly 2025 Short Interest & Free Real-Time Market Sentiment Alerts - ulpravda.ru
Klotho Neurosciences, Inc. (KLTOW) Stock Forecast & Price Prediction 2025–2030 - CoinCodex
What analysts say about Klotho Neurosciences Inc Equity Warrant stockVolume Spike Alerts & Affordable Trading Plans - earlytimes.in
Rate Cut: Is Klotho Neurosciences Inc stock a dividend growth opportunity2025 Trading Recap & Free Weekly Watchlist of Top Performers - moha.gov.vn
Will Klotho Neurosciences Inc. stock benefit from AI adoption2025 Market Outlook & Accurate Entry and Exit Point Alerts - Улправда
How interest rate cuts could boost Klotho Neurosciences Inc. Equity Warrant stockJuly 2025 Setups & Technical Pattern Alert System - Улправда
Will Klotho Neurosciences Inc. stock outperform value stocks2025 Analyst Calls & Technical Pattern Based Signals - Улправда
How Klotho Neurosciences Inc. stock reacts to job market dataMarket Trend Report & Daily Momentum Trading Reports - Улправда
What dividend safety score for Klotho Neurosciences Inc. Equity Warrant stock2025 Performance Recap & Weekly Setup with High ROI Potential - Улправда
How sustainable is Klotho Neurosciences Inc. Equity Warrant stock dividend payout2025 Fundamental Recap & Stock Portfolio Risk Management - DonanımHaber
Klotho Neurosciences, Inc. Warrant 2024-21.06.29 on Klotho Neuroscience - TradingView — Track All Markets
Can Klotho Neurosciences Inc. stock weather global recessionJuly 2025 Review & Fast Entry Momentum Alerts - Улправда
Is Klotho Neurosciences Inc. Equity Warrant stock a buy for dividend growthJuly 2025 Gainers & Free Weekly Chart Analysis and Trade Guides - DonanımHaber
How Klotho Neurosciences Inc. Equity Warrant stock compares to market leaders2025 Market Overview & Community Trade Idea Sharing - ulpravda.ru
Beyond Weight Loss: The "Cellular Reset" That Could Create the Next Biotech Supercycle - The Globe and Mail
Klotho Neurosciences enters securities purchase agreement - MSN
Klotho Neurosciences enters agreement to sell Series C preferred stock to Sigma9 Capital - Investing.com Australia
Get in on Klotho Neurosciences Inc’s (KLTO) buy-in window today! - setenews.com
Klotho Neurosciences files to sell 35M shares of common stock for holders - MSN
EBITDA per share of Klotho Neurosciences, Inc. Warrant 2024-21.06.29 on Klotho Neuroscience – NASDAQ:KLTOW - TradingView
Is Klotho Neurosciences Inc Equity Warrant a good long term investmentFlag and Pennant Patterns & Low Entry Investment Growth - earlytimes.in
Why Klotho Neurosciences Inc. Equity Warrant stock could benefit from AI revolutionJuly 2025 Technicals & Free Long-Term Investment Growth Plans - Newser
Is Klotho Neurosciences Inc. Equity Warrant stock a safe buy before earnings2025 Breakouts & Breakdowns & Safe Entry Zone Identification - Newser
Does Klotho Neurosciences Inc. Equity Warrant stock trade at a discount to peersPortfolio Return Summary & AI Driven Stock Reports - Newser
Klotho Neurosciences (KLTO) Stock Analysis Report | Financials & Insights - Benzinga
Investors in cash trouble should check out Klotho Neurosciences Inc (KLTO) - setenews.com
Klotho Neurosciences, Inc. announced that it expects to receive $14.96 million in funding from Sigma9 Capital Ltd - marketscreener.com
Klotho Neurosciences Stock Skyrockets On Anti-Aging Gene Therapy Breakthrough: Retail Traders Over The Moon - MSN
Klotho Neurosciences (NASDAQ:KLTO) Trading Down 8.8% – What’s Next? - Defense World
Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market (PR Newswire) - Aktiellt
Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease") (PR Newswire) - Aktiellt
You might want to take a look at Klotho Neurosciences Inc (KLTO) now - Setenews
Is Klotho Neurosciences Inc a good long term investmentChart Pattern Recognition & Free Daily Investment Newsletter Subscription - earlytimes.in
Does Klotho Neurosciences Inc (KLTO) offer a good opportunity for investors? - Setenews
Klotho Neurosciences Inc. Equity Warrant’s volatility index tracking explainedQuarterly Market Review & Fast Gain Swing Alerts - newser.com
How institutional buying supports Klotho Neurosciences Inc. Equity Warrant stockBond Market & Safe Entry Point Alerts - newser.com
Can you recover from losses in Klotho Neurosciences Inc.Earnings Performance Report & Weekly High Return Stock Opportunities - newser.com
Finanzdaten der Klotho Neurosciences Inc-Aktie (KLTO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):